Showing 1 - 5 results of 5 for search 'Miriam Lettieri', query time: 0.03s Refine Results
  1. 1
    An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors

    An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors by Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Luca Rinaldi, Anna Di Martino, Gaetana Albanese, Jessica Di Salvo, Raffaella Epifani, Raffaele Marfella, Giovanni Docimo, Miriam Lettieri, Celestino Sardu, Ferdinando Carlo Sasso

    Published 2022-03-01
    Get full text
    Article
  2. 2
    The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial

    The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc anal... by Ferdinando Carlo Sasso, Vittorio Simeon, Raffaele Galiero, Alfredo Caturano, Luca De Nicola, Paolo Chiodini, Luca Rinaldi, Teresa Salvatore, Miriam Lettieri, Riccardo Nevola, Celestino Sardu, Giovanni Docimo, Giuseppe Loffredo, Raffaele Marfella, Luigi Elio Adinolfi, Roberto Minutolo, NID-2 study group Investigators

    Published 2022-11-01
    Get full text
    Article
  3. 3
    A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology

    A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology by Matthew J. Birket, Sophie Raibaud, Miriam Lettieri, Antony D. Adamson, Valerie Letang, Pauline Cervello, Nicolas Redon, Gwenaelle Ret, Sandra Viale, Bing Wang, Bruno Biton, Jean-Claude Guillemot, Vincent Mikol, John P. Leonard, Neil A. Hanley, Cecile Orsini, Jean-Michel Itier

    Published 2019-08-01
    Get full text
    Article
  4. 4
    Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study

    Mortality and risk factors of vaccinated and unvaccinated frail patients with COVID-19 treated with anti-SARS-CoV-2 monoclonal antibodies: A real-world study by Riccardo Nevola, Giovanni Feola, Rachele Ruocco, Antonio Russo, Angela Villani, Raffaele Fusco, Stefania De Pascalis, Micol Del Core, Giovanna Cirigliano, Mariantonietta Pisaturo, Giuseppe Loffredo, Luca Rinaldi, Aldo Marrone, Mario Starace, Pellegrino De Lucia Sposito, Domenico Cozzolino, Teresa Salvatore, Miriam Lettieri, Raffaele Marfella, Ferdinando Carlo Sasso, Nicola Coppola, Luigi Elio Adinolfi

    Published 2023-06-01
    Get full text
    Article
  5. 5
    Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study

    Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study by Raffaele Galiero, Vittorio Simeon, Giuseppe Loffredo, Alfredo Caturano, Luca Rinaldi, Erica Vetrano, Giulia Medicamento, Maria Alfano, Domenico Beccia, Chiara Brin, Sara Colantuoni, Jessica Di Salvo, Raffaella Epifani, Riccardo Nevola, Raffaele Marfella, Celestino Sardu, Carmine Coppola, Ferdinando Scarano, Paolo Maggi, Cecilia Calabrese, Pellegrino De Lucia Sposito, Carolina Rescigno, Costanza Sbreglia, Fiorentino Fraganza, Roberto Parrella, Annamaria Romano, Giosuele Calabria, Benedetto Polverino, Antonio Pagano, Fabio Giuliano Numis, Carolina Bologna, Mariagrazia Nunziata, Vincenzo Esposito, Nicola Coppola, Nicola Maturo, Rodolfo Nasti, Pierpaolo Di Micco, Alessandro Perrella, Miriam Lettieri, Luigi Elio Adinolfi, Paolo Chiodini, Ferdinando Carlo Sasso, on behalf of COVOCA Study Group

    Published 2022-10-01
    Get full text
    Article

Search Tools: